आईएसएसएन: 2261-7434
Edith Filaire
The skin is colonized by hundreds of diverse bacterial species, which act as a part of the body’s first line of defence against the external environment. The diversity of these transient and resident microbes is determined by different characteristics of local surface areas and external factors. Dysbiosis and the decreased microbial biodiversity have been linked with many diseases, including acne and psoriasis. Seite et al. hypothesized that bacteria could affect the pathophysiology of the sensitive skin syndrome. However, the data concerning this relationship are scarce. Moreover, treatment of reactive skin is challenging and generally based on continuous and topical application of anti-sensitive moisturizing tolerance extreme product that improves skin features. On the other side, the application of marine algae in skin treatment is of huge potential due to their properties of anti-acne, antioxidant, anti-aging, and anti-inflammatory, scientists showing that marine algae derived compounds exhibit various beneficial activities on skin health and care. Among them, Halymenia durvillei (HD) is a red alga belonging to the Rhodophyceae family, containing phycocolloids, which are the constituent polysaccharides of cell membranes. The current interest in these polysaccharides is due to their known bioactivities, conferred by their anti-allergic, neuroprotective, cytotoxic, anti-nociceptive and immunomodulatory properties, making them promising bioactive products and biomaterials. Based on these data, the first aim of our investigation was to characterize the sensitive skin microbiota and to evaluate the effect of HD extract versus placebo on the bacterial skin microflora after 28 days of treatment by using next- generation sequencing experiments on samples collected from 30 volunteers suffered from reactive and sensitive skin. The second objective was to evaluate the effect of HD extract on neuroinflammation parameters using an ex vivo model. Finally, an in vivo study was performed in a panel of 25 volunteers using clinical and instrumental evaluations.